Skip to main content

Your search for “Cancer Immunotherapy” returned 113 results

Study: Endometrial Cancer Treatment Has Significant Results

March 27, 2023

Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health examined a new treatment approach for endometrial cancer.

New Clinic Matches Patients with Cancer to Latest Precision Immunotherapy Treatments

October 17, 2019

New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.

UC San Diego Health Expands Leading-Edge Cancer Care in Hillcrest

February 5, 2019

To make it easier for patients to receive world-class cancer care, UC San Diego Health has added a new multidisciplinary cancer clinic in Hillcrest and expanded its infusion center for both oncology patients and others in need of infusion services.

Why Young and Female Patients Don’t Respond as Well to Cancer Immunotherapy

August 17, 2020

UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance.

Ultrasound Remotely Triggers Immune Cells to Attack Tumors in Mice Without Toxic Side Effects

August 12, 2021

A new cancer immunotherapy pairs ultrasound with cancer-killing immune cells to destroy malignant tumors while sparing normal tissue. The approach could make chimeric antigen receptor (CAR) T-cell therapy safer and effective at treating solid tumors.

Early Biomarker for Pancreatic Cancer Identified

May 15, 2012

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.

Nanoparticle Vaccine Could Curb Cancer Metastasis to Lungs by Targeting a Protein

October 18, 2023

UC San Diego engineers have developed an experimental vaccine that could prevent the spread of metastatic cancers to the lungs. Its success lies in targeting a protein known to play a central role in cancer growth and spread, rather than targeting the primary tumor itself.

Neurosurgeon: My Patients Show Me Real Heroism and Resilience

March 11, 2024

UC San Diego Health provides the most advanced neurological cancer care by combining leading-edge surgical techniques and the latest technology.

Extrachromosomal DNA is common in human cancer and drives poor patient outcomes

August 17, 2020

The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including the University of California San Diego.

Strauss Family Gives UC San Diego $1 Million to Help Develop a Cancer Vaccine

October 17, 2017

…the doctors at Moores Cancer Center at UC San Diego Health. When their daughter’s cancer reappeared, it was the first place they turned for help. Because of their experience and trust in the medical and research staff, the couple recently donated $1 million to the University of California San Diego…

Category navigation with Social links